Topic Highlight
Copyright ©2010 Baishideng. All rights reserved
World J Gastroenterol. Jun 7, 2010; 16(21): 2591-2599
Published online Jun 7, 2010. doi: 10.3748/wjg.v16.i21.2591
Is the disease course predictable in inflammatory bowel diseases?
Peter Laszlo Lakatos, Lajos S Kiss
Peter Laszlo Lakatos, Lajos S Kiss, 1st Department of Medicine, Semmelweis University, H-1083 Budapest, Koranyi S 2A, Hungary
Author contributions: Lakatos PL and Kiss LS contributed equally to this paper.
Correspondence to: Dr. Peter Laszlo Lakatos, MD, PhD, 1st Department of Medicine, Semmelweis University, H-1083 Budapest, Koranyi S 2A, Hungary. kislakpet@bel1.sote.hu
Telephone: +36-1-2100278 Fax: +36-1-3130250
Received: November 21, 2009
Revised: December 16, 2009
Accepted: December 23, 2009
Published online: June 7, 2010
Abstract

During the course of the disease, most patients with Crohn’s disease (CD) may eventually develop a stricturing or a perforating complication, and a significant number of patients with both CD and ulcerative colitis will undergo surgery. In recent years, research has focused on the determination of factors important in the prediction of disease course in inflammatory bowel diseases to improve stratification of patients, identify individual patient profiles, including clinical, laboratory and molecular markers, which hopefully will allow physicians to choose the most appropriate management in terms of therapy and intensity of follow-up. This review summarizes the available evidence on clinical, endoscopic variables and biomarkers in the prediction of short and long-term outcome in patients with inflammatory bowel diseases.

Keywords: Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis, Disease course, Predictive markers, Clinical, Serology, Genetics